| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |